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Conference Summary
Fifth Annual 
Conference on New 
and Re-Emerging 
Infectious Diseases 
The fifth annual Conference on
New and Re-Emerging Infectious Dis-
eases was hosted on April 18–19,
2002, by the College of Veterinary
Medicine, University of Illinois at
Urbana-Champaign (UIUC). The con-
ference featured 8 speakers and 35
poster presentations. 
Recent Infectious Diseases
Beatrice Hahn (University of Ala-
bama, Birmingham, AL) opened the
conference with a presentation on the
search for the origins of HIV. The evi-
dence indicates that two simian immu-
nodeficiency viruses (SIV), one from
chimpanzees (SIVcpz) and  the other
from sooty mangabeys (SIVsm),
crossed the species barrier to humans,
generating HIV-1 and HIV-2, respec-
tively. Dr. Hahn stressed the impor-
tance of characterizing the prevalence,
geographic distribution, and genetic
diversity of naturally occurring SIV
infections to investigate whether
humans continue to be exposed to SIV
and if such exposure could lead to
additional zoonotic transmissions.
William Hueston (University of
Minnesota, St. Paul, MN) gave a per-
sonal account of how bovine spongi-
form encephalopathy (BSE), appeared
in Europe and how chronic wasting
disease (CWD,—another transmissi-
ble spon-giform encephalopathy that
affects elk and deer) is spreading
across North America. The disease
seriously affects the elk industry.
CWD causes emaciation and eventu-
ally death. The disease has been
endemic for decades in elk and wild
deer populations in southeastern Wyo-
ming, northeastern Colorado, and a
small part of Nebraska. That infec-
tions on elk farms could spread the
disease to wild populations of elk and
deer is of concern and may affect the
hunting industry, especially in eastern
states, which have large populations of
white-tailed deer.
Bioweapons
Edward Eitzen (U.S. Army Medi-
cal Research Institute of Infectious
Diseases [USAMRIID] Fort Detrick,
MD) recounted the history of state-
sponsored biological weapons pro-
grams and the emergence of bioterror-
ism by non-state participants in recent
years. The various ways biological
agents can be used as weapons and the
potential routes of exposure were dis-
cussed as prelude to the medical
effects of these agents and their effects
on the health-care system. Medical
countermeasures and other important
responses to attacks with biological
agents were highlighted, including pri-
orities for the nation to be better pre-
pared.  After the anthrax attacks in
Florida, New York, New Jersey, and
Washington, DC, the threat of biologi-
cal warfare became much more real;
however, these attacks were not the
first in the United States. Dr. Eitzen
Conference Summary
Global Infectious 
Disease Policy
At the International Conference on
Emerging Infectious Diseases 2002,
held in Atlanta, the Centers for Dis-
ease Control and Prevention (CDC)
released a document entitled, “Pro-
tecting the Nation’s Health in an Era
of Globalization: CDC’s Global Infec-
tious Disease Strategy,” which
describes plans for controlling infec-
tious diseases worldwide. The docu-
ment outlines global partnerships and
measures for improving capacity for
disease surveillance and outbreak
response and for applying proven pub-
lic health tools to the control of
emerging infectious diseases over the
next decade. In addition, the docu-
ment calls for strengthening global
initiatives for disease control, con-
ducting applied research on diseases
of international importance, and build-
ing public health training and capacity
worldwide. 
International Emerging Infections
Programs in various parts of the world
will support the activities outlined in
the global strategy document. The
International Emerging Infections Pro-
gram (IEIP), Thailand, is the first site
in the network of IEIPs proposed in the
plan. Through the IEIP network, mod-
eled after the U.S. Emerging Infections
Program, specialists will work with
local ministries of health to support
laboratory-enhanced, population-based
surveillance for infectious diseases.
Data from this surveillance will allow
ministries of health to prioritize dis-
eases, evaluate targeted interventions,
and support global efforts to prevent
and control disease. IEIPs will train
local scientists and CDC personnel,
provide diagnostic and epidemiologic
resources when outbreaks occur, and
serve as platforms for regional infec-
tious disease control activities. 
In December 2001, IEIP Thailand
and the Southeast Asia Regional Office
of the World Health Organization
hosted a training course on anthrax,
attended by 64 participants from 16
countries. In 2002, IEIP Thailand initi-
ated an investigation of an increase in
reported leptospirosis cases through a
study of hospitalized patients with
febrile illness. IEIP Thailand is plan-
ning studies of respiratory illness and
encephalitis later this year; a second
IEIP site will be launched soon. 
The Global Infectious Disease
Strategy document is available at http:/
/www.cdc.gov/globalidplan. Supple-
mentary materials are available at
http://www.cdc.gov/ncidod. For a print
copy of the strategy, send a request by
e-mail to ncid@cdc.gov; or by fax to
404-639-4194; or contact NCID,
Office of Health Communications,
1600 Clifton Road, NE, Mailstop C14,
Atlanta, GA 30333 USA.
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described USAMRID’s role in detect-
ing contaminated material and helping
in the clean-up effort in the response
to the anthrax attack.
Cholera and Multidrug-Resistant 
Tuberculosis
A filamentous bacteriophage
(CTXφ ) integrated in the Vibrio chol-
erae chromosome encodes the chol-
era toxin, and Matthew Waldor (New
England Medical Center, Boston, MA)
described another phage (RS1) that
flanks the CTXφ   prophage in the bac-
terial chromosome and is important
for the CTXφ  prophage propagation.
RS1 relies upon CTXφ –encoded pro-
teins for packaging and secretion of its
genome; however, RS1 is not simply a
parasite, as it can aid the CTXφ
prophage while exploiting it.  The
unique RS1-encoded protein RstC is
an antirepressor that counteracts the
activity of the CTXφ  repressor, RstR.
RstC and RstR appear to form intrac-
ellular aggregates that prevent the
repressor from binding to its opera-
tors.  Inactivation of RstR results in
increased transcription of CTXφ  genes
and increased transmission of both
RS1 and CTXφ .
Tuberculosis remains a major glo-
bal health burden: an estimated one
third of the world is infected with
Mycobacterium tuberculosis. The suc-
cessful spread of this slow-growing
airborne bacteria continues to be a
public health challenge. Current prob-
lems are further complicated by the
rise of multidrug-resistant (MDR)
strains, the failure to develop new
anti-mycobacterial drugs, and the
deadly marriage between HIV and TB.
Two genotyping networks have gener-
ated data on >60,000 clinical isolates
of  M. tuberculosis, as indicated by
Barry N. Kreiswirth (Public Health
Research Institute, New York, NY).
Unique genetic markers were identi-
fied to distinguish various branches of
the  M. tuberculosis genetic lineage
that are associated with large MDR
outbreaks, such as the drug-resistant
W strain that spread through New
York State prisons and New York City
hospitals. Outbreaks with related
clones were also identified in regions
of the United States, Russia, South
Africa, and in several Asian counties.
Preliminary evidence indicates that
members of this lineage grow better in
macrophage cell lines and are hyper-
virulent, causing early death in immu-
nocompetent mice.
Re-Emerging Parasitic Diseases
Through vigorous efforts made in
the past two centuries, public health
workers have succeeded in developing
vaccines, antibiotics, and chemothera-
peutics, and as a result most infectious
diseases have been brought under con-
trol in industrialized countries. How-
ever, in developing countries,
infectious diseases have been harder
to contain, and the increase in migra-
tion and movement of populations in
the last two decades has made national
boundaries disappear as far as the
transmission of infection is concerned.
Some diseases, such as malaria, have
been eradicated from industrialized
countries mainly through extensive
work on vector control, but their pres-
ence in developing countries has
increased because of neglect or drug
resistance. Donald Goldberg (Wash-
ington University, St. Louis, MO)
showed how the Malaria Genome
Project helped to find novel proteases,
several of which appear to function in
hemoglobin metabolism. One of these
proteases (Histidine Aspartic Protease,
HAP) is homologous to three other
aspartic proteases involved in hemo-
globin metabolism but has a histidine
in place of one of the two aspartic
acids involved in catalysis. Despite
this change, HAP is an active protease
with distinct properties, and together
with a series of cysteine and metallo-
proteases and a dipeptidyl peptidase,
provides attractive focus for antima-
larial drug development.
African trypanosomiasis has
reached epidemic proportions in
recent years, and its etiologic agents
have become noteworthy among
molecular biologists for their ability to
use genomic rearrangements to
change their major surface protein
(variant surface protein, VSG). John
Donelson (University of Iowa, Iowa
City, IA) reviewed antigenic variation
in  Trypanosoma brucei and recent
findings on the use of an extranucle-
olar body containing RNA polymerase
I to regulate expression of VSG genes.
Donelson provided examples of how
the African Trypanosome Genome
Project has helped to elucidate the
sequence of new expression site-asso-
ciated genes (ESAGs) and how the
RNA interference technique has con-
tributed to identifying essential roles
of ESAGs in the T. brucei life cycle.
Leishmaniasis has recently
emerged as an opportunistic infection
after the advent of the AIDS epidemic.
Kwang-Poo Chang (Chicago Medical
School, Chicago, IL) proposed a
hypothetical model to account for
nontoxigenic microbial virulence
involving two groups of different mol-
ecules of parasite origin. One group is
responsible for invasion and evasion
of mammalian hosts by Leishmania to
achieve infection but does not directly
cause the disease or virulence pheno-
type. For example, repeated injections
of animals with these molecules, such
as gp63 and LPG, do not result in any
visible disease signs. The other group
is formed by immunoreactive epitopes
whose interactions with the host
immune system result in immunopa-
thology, accounting for the clinical
symptoms. The proposed examples
include B-cell epitopes specific to
Leishmania identified by a number of
laboratories working with visceral
Leishmania spp. All have been found
in the parasite’s cytoplasm often as
complex proteins, i.e., ribosomes,
nucleosomes (histones), chaper-
onines, structural proteins (tubulins,
kinesin), glycosomes (triose phos-
phate isomerase). These epitopes are
unique to Leishmania molecules not
shared with those found in autoim-
mune diseases. One example is the
anti-K39 antibodies in kala-azar. K-39
is referred to as 39 aa repetitive pep-
tides found in a kinesin-like gene (5
kb), which is expressed only by theNEWS & NOTES
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amastigotes of visceral Leishmania
spp. The anti-K39 antibodies in Indian
kala-azar, for example, reach a titer as
much as 1:1,000,000. This antibody
and other specific anti-Leishmania
antibodies are nonprotective, as they
cannot reach the intracellular antigens
within amastigotes inside macro-
phages but contribute to the hemato-
logic disorders of kala-azar, such as
albumin: immunoglobulin G ratio
reversal, and hyperplasia of B-cell
populations in the lymphoid organs. 
The poster section highlighted
recent work on several emerging
infectious diseases. Using a cell line in
which tubulin was labeled with the
fluorescent indicator green fluorescent
protein (GFP) and immunofluores-
cence  assay, G.W. Gant Luxton and
Kevin Tyler (Northwestern University
[NWU], Chicago, IL) demonstrated a
rapid association of host tubulins with
the plasma membrane at the site of
Trypanosoma cruzi contact. Juan
Leon, from the same laboratory
(NWU), showed that captopril, an
antifibrotic angiotensin-converting
enzyme inhibitor, is effective in ame-
liorating experimental autoimmune
myocarditis and experimental Chagas
heart disease. Ileana Cuevas from the
Daniel Sanchez Laboratory (Univer-
sity of General San Martin, San Mar-
tin, Argentina) reported the presence
of a farnesylated protein tyrosine
phosphatase in T. cruzi. Carlos Lopez-
Estraño (NWU) reported experiments
using truncated versions of histidine-
rich protein II with green fluorescent
protein to investigate how they are
transported to the malaria-infected
erythrocyte cytosol.
N-acetylglucosamine-1-phosphate
transferase gene is a potential marker
for genotyping Old World Leishmania
isolates, as reported by Kayoko Waki
(Chicago Medical School, Chicago,
IL). A thioredoxin and a thioredoxin-
glutathione reductase are present in
Schistosoma mansoni, as reported by
David Williams (Illinois State Univer-
sity, Normal, IL). Thioredoxin is
present in egg-secretory products and
is a novel B-cell antigen in schisto-
some-infected mice. Schistosomes
appear to be the first example of an
organism with a redox system based
exclusively on thioredoxin-glu-
tathione reductase.
Ibulaimu Kakoma's (UIUC,
Urbana) and Byeong-Kirl Baek’s
(Chonbuk, Korea) laboratories
reported the use of polymerase chain
reaction to verify vertical transmission
of  Theileria sergenti in cows, an
important problem for the control of
theileriosis. Kakoma and Baek also
reported the characterization of the
protective response in rats against
homologous challenge infections with
Strongyloides venezuelensis. Finally,
Anna M. Schotthoefer (UIUC,
Urbana) reported that infection with
the larval trematode Ribeiroia
ondatrae could be responsible for
limb malfomations in tadpoles and
could explain the observed increase in
the frequency of these malformations
within natural frog populations. 
In summary, this interdisciplinary
conference generated stimulating dis-
cussions on various aspects of emerg-
ing and re-emerging infectious
diseases. Since two SIV viruses were
the cause of AIDS in humans, other
SIVs can potentially infect humans
and cause disease. The spread of
chronic wasting disease from elk
farms to wild populations of elk and
deer in North America is of great con-
cern. Genetic markers have been a
great resource to identify MDR strains
of M. tuberculosis. The interaction of
the cholera toxin-encoding phage with
an additional phage in the genome of
V. cholerae has unexpected conse-
quences for their transmission. Non–
state-sponsored bioterrorism has
changed our appreciation of bioweap-
ons. Parasitic diseases, such as
malaria, African trypanosomiasis, and
leishmaniasis have re-emerged in
recent years and the study of their
agents has provided potential focus for
their chemotherapy and insights into
microbial virulence.
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